Ontology highlight
ABSTRACT: Background
Pyrazinamide (PZA) is often used as an add-on agent in the treatment of multidrug-resistant tuberculosis, regardless of phenotypic drug susceptibility testing (pDST) results. However, evaluating the effectiveness of PZA is challenging because of its low pH activity, which can result in unreliable pDST results. This study aimed to investigate the genomic characteristics associated with PZA resistance that can be used to develop genotypic DST.Materials and methods
A publicly available whole genome sequencing (WGS) dataset of 10,725 Mycobacterium tuberculosis complex genomes (3,326 phenotypically PZA-resistant and 7,399 phenotypically PZA-susceptible isolates) were analyzed.Results
In total, 2,934 pncA non-silent mutations were identified in 2,
SUBMITTER: Kim NY
PROVIDER: S-EPMC10323538 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature